Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 0/25
Result 14,872 decisions over 12 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
26 Dec 2025
10% owner indirect
Bought
229,917
$3.58M
3.3%
26 Dec 2025
10% owner indirect
Bought
229,917
$3.58M
3.3%
26 Dec 2025
10% owner indirect
Bought
229,917
$3.58M
3.3%
26 Dec 2025
Director indirect
Bought
229,917
$3.58M
3.3%
26 Dec 2025
Chief Scientific Officer
Sold at will
90,000
$3.49M
39.1%
26 Dec 2025
Chief Medical Officer
Sold at will
82,642
$3.20M
38.2%
26 Dec 2025
Co-Founder
Sold on a plan
30,000
$3.07M
6.4%
26 Dec 2025
Chief Executive Officer
Sold on a plan
30,000
$3.07M
6.4%
26 Dec 2025
Chief Financial Officer
Sold at will
77,000
$2.98M
36.9%
26 Dec 2025
President and CEO indirect
Sold on a plan
632,874
$2.89M
22.0%
26 Dec 2025
10% owner
Sold at will
3,689,016
$2.77M
1.4%
26 Dec 2025
Chief Legal Officer
Sold at will
65,000
$2.52M
37.3%
26 Dec 2025
Chairman and CEO
Sold at will
20,000
$2.20M
0.2%
26 Dec 2025
President and CEO
Sold on a plan
19,416
$2.17M
0.4%
26 Dec 2025
10% owner indirect
Bought
385,850
$1.71M
5.8%
26 Dec 2025
Director
Bought
167,500
$1.68M
opened
26 Dec 2025
Chief Accounting Officer
Sold on a plan
43,872
$1.55M
74.5%
26 Dec 2025
Co-Founder Chief Strategy Off.
Sold on a plan
73,782
$1.43M
6.0%
26 Dec 2025
Director indirect
Sold on a plan
7,665
$1.25M
25.0%
26 Dec 2025
CEO, Co-Founder indirect
Sold on a plan
7,665
$1.25M
25.0%
26 Dec 2025
President
Sold on a plan
6,218
$1.17M
4.0%
26 Dec 2025
10% owner indirect
Sold at will
75,521
$1.04M
1.3%
26 Dec 2025
EVP, Gen. Counsel & Corp. Sec.
Sold at will
2,872
$1.00M
17.9%
24 Dec 2025
Chief Strategy Officer indirect
Sold on a plan
281,250
$22.32M
100%
24 Dec 2025
10% owner
Bought on a plan
220,000
$15.51M
0.4%
24 Dec 2025
10% owner indirect
Sold on a plan
378,474
$11.41M
3.8%
24 Dec 2025
President and Chairman indirect
Sold on a plan
378,474
$11.41M
3.8%
24 Dec 2025
10% owner indirect
Sold at will
1,000,000
$7.50M
26.7%
24 Dec 2025
EVP & GENERAL COUNSEL
Sold on a plan
11,000
$5.64M
23.0%
24 Dec 2025
10% owner indirect
Bought
875,548
$4.05M
3.3%
24 Dec 2025
Pres., Global Field Operations
Sold at will
15,000
$2.95M
6.0%
24 Dec 2025
10% owner
Sold at will
2,629
$2.85M
0.0%
24 Dec 2025
10% owner indirect
Bought
167,519
$2.65M
2.5%
24 Dec 2025
10% owner indirect
Bought
167,519
$2.65M
2.5%
24 Dec 2025
10% owner indirect
Bought
167,519
$2.65M
2.5%
24 Dec 2025
Director indirect
Bought
167,519
$2.65M
2.5%
24 Dec 2025
10% owner indirect
Bought
100,000
$2.48M
0.3%
24 Dec 2025
Chief Research Officer
Sold on a plan
60,000
$2.41M
37.2%
24 Dec 2025
President and CEO indirect
Sold on a plan
449,997
$2.10M
13.5%
24 Dec 2025
10% owner indirect
Bought
438,333
$1.93M
7.0%
24 Dec 2025
President & Immunovant CEO
Sold at will
75,000
$1.69M
4.3%
24 Dec 2025
Chief Legal Officer, Secretary
Sold at will
10,000
$1.50M
4.4%
24 Dec 2025
Director indirect
Sold on a plan
33,356
$1.49M
0.9%
24 Dec 2025
Director indirect
Sold on a plan
33,356
$1.49M
0.9%
24 Dec 2025
Chairman and CEO
Sold at will
12,400
$1.35M
0.1%
24 Dec 2025
Director indirect
Sold on a plan
7,665
$1.23M
20.0%
24 Dec 2025
CEO, Co-Founder indirect
Sold on a plan
7,665
$1.23M
20.0%
24 Dec 2025
Director
Bought
15,000
$1.08M
2.7%
23 Dec 2025
President and CEO indirect
Sold at will 12×
100,000
$34.56M
16.8%
23 Dec 2025
10% owner
Sold on a plan
80,279
$17.26M
43.3%
Showing 11,351–11,400 of 14,872. ← Newer Page 228 of 298 Older →